{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T11:35:52Z","timestamp":1778326552219,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T00:00:00Z","timestamp":1627430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T00:00:00Z","timestamp":1627430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Familial neurohypophysial diabetes insipidus (FNDI), commonly caused by autosomal dominant <jats:italic>arginine vasopressin (AVP)<\/jats:italic> mutations, is a rare condition in which vasopressin fails in regulating body\u2019s level of water with final polyuria and polydipsia. Genetic testing in familial cases of FNDI should be carry out to ensure adequate treatments and avoid disease manifestations especially in infants.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, we investigated three-generations of a large Italian family with clinical diagnosis of familial central diabetes insipidus for the presence of potential pathogenic mutations in the AVP gene.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We identified a heterozygous missense mutation (c.154\u2009T\u2009&gt;\u2009A; p.C52S) in AVP gene in all affected members studied of a large Italian family. In <jats:italic>silico<\/jats:italic> tools were used to investigate the pathogenic role of the mutation and three-dimensional protein structure predicted that the p.C52S impairs disulfide bridges formation resulting in misfolding of the protein.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This is the first study that identified a novel missense p.C52S mutation as causative of central diabetes insipidus in a large Italian pedigree.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s12020-021-02830-x","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T10:02:48Z","timestamp":1627466568000},"page":"188-192","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Autosomal dominant familial neurohypophyseal diabetes insipidus caused by a novel missense mutation in AVP gene in a large Italian kindred"],"prefix":"10.1007","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8573-4913","authenticated-orcid":false,"given":"Carlotta","family":"Marzocchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5741-295X","authenticated-orcid":false,"given":"Silvia","family":"Cantara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2247-9027","authenticated-orcid":false,"given":"Alfonso","family":"Sagnella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2457-1751","authenticated-orcid":false,"given":"Maria Grazia","family":"Castagna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8624-5831","authenticated-orcid":false,"given":"Marco","family":"Capezzone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,28]]},"reference":[{"key":"2830_CR1","doi-asserted-by":"publisher","unstructured":"J.H. Christensen, S. Rittig, Familial neurohypophyseal diabetes insipidus-an update. Semin. Nephrol. (2006). https:\/\/doi.org\/10.1016\/j.semnephrol.2006.03.003","DOI":"10.1016\/j.semnephrol.2006.03.003"},{"key":"2830_CR2","doi-asserted-by":"publisher","unstructured":"H. Arima, Y. Oiso, Mechanisms underlying progressive polyuria in familial neurohypophysial diabetes insipidus. J. Neuroendocrin. (2010). https:\/\/doi.org\/10.1111\/j.1365-2826.2010.02028.x","DOI":"10.1111\/j.1365-2826.2010.02028.x"},{"key":"2830_CR3","doi-asserted-by":"publisher","unstructured":"D. Hagiwara, V. Grinevich, H. Arima, A novel mechanism of autophagy-associated cell death of vasopressin neurons in familial neurohypophysial diabetes insipidus. Cell Tissue Res. (2019). https:\/\/doi.org\/10.1007\/s00441-018-2872-4","DOI":"10.1007\/s00441-018-2872-4"},{"key":"2830_CR4","doi-asserted-by":"publisher","unstructured":"M. Babey, P. Kopp, G.L. Robertson, Familial forms of diabetes insipidus: clinical and molecular characteristics. Nat. Rev. Endocrinol. (2011). https:\/\/doi.org\/10.1038\/nrendo.2011.100","DOI":"10.1038\/nrendo.2011.100"},{"key":"2830_CR5","doi-asserted-by":"publisher","unstructured":"N. Di Iorgi, A.E. Allegri, F. Napoli, A. Calcagno, E. Calandra, N. Fratangeli, M. Vannati, A. Rossi, F. Bagnasco, R. Haupt, et al., Central diabetes insipidus in children and young adults: etiological diagnosis and long-term outcome of idiopathic cases. J. Clin. Endocrinol. Metab. (2014). https:\/\/doi.org\/10.1210\/jc.2013-3724","DOI":"10.1210\/jc.2013-3724"},{"key":"2830_CR6","doi-asserted-by":"publisher","unstructured":"H. Land, M. Grez, S. Ruppert, H. Schmale, M. Rehbein, D. Richter, G. Sch\u00fctz, Deduced amino acid sequence from the bovine oxytocin-neurophysin I precursor cDNA. Nature (1983). https:\/\/doi.org\/10.1038\/302342a0","DOI":"10.1038\/302342a0"},{"key":"2830_CR7","doi-asserted-by":"publisher","unstructured":"M.L. Kortenoeven, N.B. Pedersen, L.L. Rosenbaek, R.A. Fenton, Vasopressin regulation of sodium transport in the distal nephron and collecting duct. Am. J. Physiol. Renal. Physiol. (2015). https:\/\/doi.org\/10.1152\/ajprenal.00093.2015","DOI":"10.1152\/ajprenal.00093.2015"},{"key":"2830_CR8","doi-asserted-by":"publisher","unstructured":"M.H. Schernthaner-Reiter, C.A. Stratakis, A. Luger, Genetics of diabetes insipidus. Endocrinol. Metab. Clin. North Am. (2017). https:\/\/doi.org\/10.1016\/j.ecl.2017.01.002","DOI":"10.1016\/j.ecl.2017.01.002"},{"key":"2830_CR9","doi-asserted-by":"publisher","unstructured":"P.D. Stenson, M. Mort, E.V. Ball, K. Evans, M. Hayden, S. Heywood, M. Hussain, A.D. Phillips, D.N. Cooper, The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies. Hum. Genet. (2017). https:\/\/doi.org\/10.1007\/s00439-017-1779-6","DOI":"10.1007\/s00439-017-1779-6"},{"key":"2830_CR10","doi-asserted-by":"publisher","unstructured":"M. Spiess, M. Friberg, N. Beuret, C. Prescianotto-Baschong, J. Rutishauser, Role of protein aggregation and degradation in autosomal dominant neurohypophyseal diabetes insipidus. Mol. Cell Endocrinol. (2020). https:\/\/doi.org\/10.1016\/j.mce.2019.110653","DOI":"10.1016\/j.mce.2019.110653"},{"key":"2830_CR11","doi-asserted-by":"publisher","unstructured":"M. Ito, R.N. Yu, J.L. Jameson, Mutant vasopressin precursors that cause autosomal dominant neurohypophyseal diabetes insipidus retain dimerization and impair the secretion of wild-type proteins. J. Biol. Chem. (1999). https:\/\/doi.org\/10.1074\/jbc.274.13.9029","DOI":"10.1074\/jbc.274.13.9029"},{"key":"2830_CR12","first-page":"105","volume":"2","author":"NQ Goking","year":"2001","unstructured":"N.Q. Goking, B.S. Chertow, G.L. Robertson, S. Ritting, C. Siggaard, E.B. Pedersen, A novel AVP-Neurophysin gene mutation in familial neurohypophyseal diabetes insipidus presenting with nocturnal enuresis. J Endocrine Genet. 2, 105\u2013113 (2001)","journal-title":"J Endocrine Genet."},{"key":"2830_CR13","doi-asserted-by":"publisher","unstructured":"M.I. Alvelos, \u00c2. Francisco, L. Gomes, I. Paiva, M. Melo, P. Marques, S. Gama-de-Sousa, S. Carreiro, T. Quintela, I. Gon\u00e7alves, M.C. Lemos, Familial neurohypophyseal diabetes insipidus: clinical, genetic and functional studies of novel mutations in the arginine vasopressin gene. Pituitary (2021). https:\/\/doi.org\/10.1007\/s11102-020-01119-y","DOI":"10.1007\/s11102-020-01119-y"},{"key":"2830_CR14","doi-asserted-by":"publisher","unstructured":"C. Brachet, J. Birk, C. Christophe, S. Tenoutasse, B. Velkeniers, C. Heinrichs, J. Rutishauser, Growth retardation in untreated autosomal dominant familial neurohypophyseal diabetes insipidus caused by one recurring and two novel mutations in the vasopressin-neurophysin II gene. Eur. J. Endocrinol. (2011). https:\/\/doi.org\/10.1530\/EJE-10-0823","DOI":"10.1530\/EJE-10-0823"},{"key":"2830_CR15","doi-asserted-by":"publisher","unstructured":"M.T. Wolf, J. D\u00f6tsch, M. Metzler, M. Holder, R. Repp, W. Rascher, A new missense mutation of the vasopressin-neurophysin II gene in a family with neurohypophyseal diabetes insipidus. Horm. Res. (2003). https:\/\/doi.org\/10.1159\/000072526","DOI":"10.1159\/000072526"},{"key":"2830_CR16","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/s1043-2760(97)00157-4","volume":"8","author":"LK Hansen","year":"1997","unstructured":"L.K. Hansen, S. Rittig, G.L. Robertson, Genetic basis of familial neurohypophyseal diabetes insipidus. Trends Endocrinol. Metab. 8, 363\u2013372 (1997). https:\/\/doi.org\/10.1016\/s1043-2760(97)00157-4","journal-title":"Trends Endocrinol. Metab."},{"key":"2830_CR17","doi-asserted-by":"publisher","unstructured":"N. Skordis, P.C. Patsalis, J.A. Hettinger, M. Kontou, E. Herakleous, M.R. Krishnamani, J.A. Phillips 3rd, A novel arginine vasopressin-neurophysin II mutation causes autosomal dominant neurohypophyseal diabetes insipidus and morphologic pituitary changes. Horm Res. (2000). https:\/\/doi.org\/10.1159\/000023573","DOI":"10.1159\/000023573"},{"key":"2830_CR18","doi-asserted-by":"publisher","unstructured":"C.E. Fl\u00fcck, J. Delado\u00eby, S. Nayak, O. Zeller, P. Kopp, P.E. Mullis, Autosomal dominant neurohypophyseal diabetes insipidus in a Swiss family, caused by a novel mutation (C59Delta\/A60W) in the neurophysin moiety of prepro-vasopressin-neurophysin II (AVP-NP II). Eur. J. Endocrinol. (2001). https:\/\/doi.org\/10.1530\/eje.0.1450439","DOI":"10.1530\/eje.0.1450439"},{"key":"2830_CR19","first-page":"783","volume":"118","author":"AP Abbes","year":"2006","unstructured":"A.P. Abbes, H. Engel, E.J. Bruggeman, A.A. Franken, Gene symbol: AVP. Disease: Diabetes insipidus, neurohypophyseal. Accession #Hm0558. Hum Genet. 118, 783 (2006)","journal-title":"Hum Genet."},{"key":"2830_CR20","doi-asserted-by":"publisher","unstructured":"Y. Luo, B. Wang, Y. Qiu, C. Zhang, C. Jin, Y. Zhao, Q. Zhu, X. Ma, Clinical and molecular analysis of a Chinese family with autosomal dominant neurohypophyseal diabetes insipidus associated with a novel missense mutation in the vasopressin-neurophysin II gene. Endocrine (2012). https:\/\/doi.org\/10.1007\/s12020-012-9606-2","DOI":"10.1007\/s12020-012-9606-2"},{"key":"2830_CR21","first-page":"107","volume":"58","author":"S Rittig","year":"1996","unstructured":"S. Rittig, G.L. Robertson, C. Siggaard, L. Kov\u00e1cs, N. Gregersen, J. Nyborg, E.B. Pedersen, Identification of 13 new mutations in the vasopressin-neurophysin II gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidus. Am J Hum Genet 58, 107\u2013117 (1996)","journal-title":"Am J Hum Genet"},{"key":"2830_CR22","doi-asserted-by":"publisher","unstructured":"S. Baglioni, G. Corona, M. Maggi, M. Serio, A. Peri, Identification of a novel mutation in the arginine vasopressin-neurophysin II gene affecting the sixth intrachain disulfide bridge of the neurophysin II moiety. Eur. J. Endocrinol. (2004). https:\/\/doi.org\/10.1530\/eje.0.1510605","DOI":"10.1530\/eje.0.1510605"},{"key":"2830_CR23","doi-asserted-by":"publisher","unstructured":"J.H. Christensen, C. Siggaard, T.J. Corydon, L. deSanctis, L. Kovacs, G.L. Robertson, N. Gregersen, S. Rittig, Six novel mutations in the arginine vasopressin gene in 15 kindreds with autosomal dominant familial neurohypophyseal diabetes insipidus give further insight into the pathogenesis. Eur. J. Hum. Genet. (2004). https:\/\/doi.org\/10.1038\/sj.ejhg.5201086","DOI":"10.1038\/sj.ejhg.5201086"},{"key":"2830_CR24","first-page":"545","volume":"123","author":"EJ Bruggeman","year":"2008","unstructured":"E.J. Bruggeman, Gene symbol: AVP. Disease: Diabetes Insipidus, neurohypophyseal. Hum Genet 123, 545 (2008)","journal-title":"Hum Genet"},{"key":"2830_CR25","doi-asserted-by":"publisher","unstructured":"D. Tian, J. Cen, M. Nie, F. Gu, Identification of five novel arginine vasopressin gene mutations in patients with familial neurohypophyseal diabetes insipidus. Int. J. Mol. Med. (2016). https:\/\/doi.org\/10.3892\/ijmm.2016.2703","DOI":"10.3892\/ijmm.2016.2703"},{"key":"2830_CR26","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1093\/clinchem\/46.10.1699","volume":"46","author":"AP Abbes","year":"2000","unstructured":"A.P. Abbes, B. Bruggeman, E.L. van Den Akker, M.R. de Groot, A.A. Franken, V.R. Drexhage, H. Engel, Identification of two distinct mutations at the same nucleotide position, concomitantly with a novel polymorphism in the vasopressin-neurophysin II gene (AVP-NP II) in two dutch families with familial neurohypophyseal diabetes insipidus. Clin. Chem. 46, 1699\u20131702 (2000)","journal-title":"Clin. Chem."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02830-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-021-02830-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02830-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T09:34:17Z","timestamp":1631612057000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-021-02830-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,28]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["2830"],"URL":"https:\/\/doi.org\/10.1007\/s12020-021-02830-x","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,28]]},"assertion":[{"value":"26 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study were in accordance with the local ethical committee (Comitato Etico Regione Toscana, Area Vasta Sud Est, AOUS).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent has been required and signed by each patients enrolled in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}